The “Cadillac Tax,” Congress 101, and More from CRS
Several new reports from the Congressional Research Service examine the implications of the 40% excise tax on high-cost employer-sponsored health care coverage, known as the “Cadillac tax,” that will take effect in 2018.
Excise Tax on High-Cost Employer-Sponsored Health Coverage: In Brief, August 14, 2015
The Excise Tax on High-Cost Employer-Sponsored Health Insurance: Estimated Economic and Market Effects, August 20, 2015
The Excise Tax on High-Cost Employer-Sponsored Health Coverage: Background and Economic Analysis, August 20, 2015
Other newly-updated CRS reports introduce the basic legislative functions of Congress, perhaps for novice Members and staff.
Resolving Legislative Differences in Congress: Conference Committees and Amendments Between the Houses, August 3, 2015
House Committee Hearings: Preparation, August 25, 2015
House Committee Hearings: Arranging Witnesses, August 25, 2015
House Committee Hearings: Scheduling and Notification, August 25, 2015
Calendars of the House of Representatives, August 25, 2015
Pairing in Congressional Voting: The House, August 25, 2015
Quorum Requirements in the House: Committee and Chamber, August 25, 2015
Amendments in the Senate: Types and Forms, August 25, 2015
Amendments in the House: Types and Forms, August 21, 2015
How Measures Are Brought to the Senate Floor: A Brief Introduction, August 5, 2015
Introducing a House Bill or Resolution, August 6, 2015
House Committee Hearings: Witness Testimony, August 10, 2015
Types of Committee Hearings, August 10, 2015
Delegates to the U.S. Congress: History and Current Status, August 25, 2015
Our analysis of federal AI governance across administrations shows that divergent compliance procedures and uneven institutional capacity challenge the government’s ability to deploy AI in ways that uphold public trust.
From California to New Jersey, wildfires are taking a toll—costing the United States up to $424 billion annually and displacing tens of thousands of people. Congress needs solutions.
To secure the U.S. bio-infrastructure, maintain global leadership in biotechnology, and safeguard American citizens from emerging threats to their privacy, the federal government must modernize its approach to human genetic and biological data.
To ensure an energy transition that brings broad based economic development, participation, and direct benefits to communities, we need federal policy that helps shape markets. Unfortunately, there is a large gap in understanding of how to leverage federal policy making to support access to capital and credit.